Results 1 to 10 of about 27,905 (224)

Beta secretase activity in peripheral nerve regeneration [PDF]

open access: yesNeural Regeneration Research, 2017
While the peripheral nervous system has the capacity to regenerate following a nerve injury, it is often at a slow rate and results in unsatisfactory recovery, leaving patients with reduced function.
Carolyn Tallon, Mohamed H Farah
doaj   +4 more sources

Adenosine triphosphate binding cassette subfamily C member 1 (ABCC1) overexpression reduces APP processing and increases alpha- versus beta-secretase activity, in vitro [PDF]

open access: yesBiology Open, 2021
The organic anion transporter Adenosine triphosphate binding cassette subfamily C member 1 (ABCC1), also known as MRP1, has been demonstrated in murine models of Alzheimer's disease (AD) to export amyloid beta (Abeta) from the endothelial cells of the ...
Wayne M. Jepsen   +7 more
doaj   +2 more sources

Beta-Secretase 1 Underlies Reactive Astrocytes and Endothelial Disruption in Neurodegeneration. [PDF]

open access: yesFront Cell Neurosci, 2021
Dysfunction in the neurovascular unit (NVU) is a key component in the progressive deterioration of Alzheimer’s disease (AD) and is critical in vascular dementia. Recent studies have shown that inflammation plays early and perhaps causal roles in the pathogenesis of AD related to NVU damage, possibly in part by overactivating the aspartic acid protease ...
Chacón-Quintero MV   +4 more
europepmc   +5 more sources

Repression of Alzheimer's beta-secretase. [PDF]

open access: yesAging (Albany NY), 2013
Alzheimer's disease (AD) is one of the most devastating neuro-degenerative disorders characterized by the two pathological hallmarks of amyloid plaques and neurofibrillary tangles. Multiple environmental factors, such as diet and life style, along with genetic factors are all significant contributors.
Liao FF, Wang R, Park EA.
europepmc   +3 more sources

Results of Beta Secretase-Inhibitor Clinical Trials Support Amyloid Precursor Protein-Independent Generation of Beta Amyloid in Sporadic Alzheimer’s Disease [PDF]

open access: yesMedical Sciences, 2018
The present review analyzes the results of recent clinical trials of β secretase inhibition in sporadic Alzheimer’s disease (SAD), considers the striking dichotomy between successes in tests of β-site Amyloid Precursor Protein-Cleaving ...
Vladimir Volloch, Sophia Rits
doaj   +2 more sources

Increased Serum Beta-Secretase 1 Activity is an Early Marker of Alzheimer's Disease. [PDF]

open access: yesJ Alzheimers Dis, 2022
Background: Beta-site APP cleaving enzyme 1 (BACE1) is the rate-limiting enzyme in amyloid-β (Aβ) plaques formation. BACE1 activity is increased in brains of patients with Alzheimer’s disease (AD) and mild cognitive impairment (MCI) and plasma levels of BACE1 appears to reflect those in the brains.
Nicsanu R   +14 more
europepmc   +3 more sources

The Alzheimer's disease β-secretase enzyme, BACE1 [PDF]

open access: yesMolecular Neurodegeneration, 2007
The pathogenesis of Alzheimer's disease is highly complex. While several pathologies characterize this disease, amyloid plaques, composed of the β-amyloid peptide are hallmark neuropathological lesions in Alzheimer's disease brain.
Sarah L Cole, Robert Vassar
core   +5 more sources

BACE1, the Alzheimer’s beta-secretase enzyme, in health and disease [PDF]

open access: yesMolecular Neurodegeneration, 2012
The beta-amyloid (Abeta) peptide is the major constituent of amyloid plaques in Alzheimer’s disease (AD) brain and is likely to play a central role in the pathogenesis of this devastating neurodegenerative disorder. The beta-secretase, beta-site amyloid precursor protein cleaving enzyme 1 (BACE1; also called Asp2, memapsin 2), is the enzyme responsible

core   +5 more sources

The beta secretase BACE1 regulates the expression of insulin receptor in the liver [PDF]

open access: yesNature Communications, 2018
A soluble form of insulin receptor in human plasma has been previously reported. Here the authors demonstrate that insulin receptor is cleaved by BACE1 that can regulate biological active insulin receptor levels in a glucose concentration-dependent ...
Paul J. Meakin   +11 more
doaj   +2 more sources

The therapeutic potential of beta-carotene against neuroinflammation and amyloid beta in SH-SY5Y cells [PDF]

open access: yesScientific Reports
Neurodegenerative diseases, particularly Alzheimer’s disease (AD), represent a significant public health challenge due to their increasing prevalence and the lack of effective treatments.
Muhammad Imran Khan   +5 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy